According to research by Tang et al., NASH patients had considerably higher levels of the hepatic expression of Th17 cell-related genes (retinoid-related orphan receptor gamma (ROR)γt, IL-17, IL-21 and IL-23) than healthy controls. Here, IL23A is linked to metabolic dysfunction-associated steatohepatitis.